This indicates that tumorigenic K-Pα(+)S KS cells are more adapted to withstand oncogenic KSHV lytic gene expression possibly by upregulating oncogenic pathways, but also by repressing innate immune response genes upon induction of the lytic replication program (Fig 8). This evidence concerns the gene LRP1 and Kaposi's sarcoma.